Cargando…
Bupropion-Induced Severe Leukocytosis
Bupropion hydrochloride is a norepinephrine-dopamine reuptake inhibitor approved for the treatment of depression and smoking cessation. Although cardiovascular and hematological side effects are common with bupropion along with weight loss and headache, hematological side effects are rarely reported...
Autores principales: | Jolly, Taranjeet S, Singh, Jatinder, Baweja, Raman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678766/ https://www.ncbi.nlm.nih.gov/pubmed/33224676 http://dx.doi.org/10.7759/cureus.11083 |
Ejemplares similares
-
The Relationship Between Colles’ Fractures and Leukocytosis in the Emergency Department
por: Hsieh, Min-Yi, et al.
Publicado: (2022) -
Leukocytosis and Spurious Hypoxemia
por: Gupta, Sachin, et al.
Publicado: (2021) -
Etiologies of Extreme Leukocytosis
por: Viner, Esther, et al.
Publicado: (2023) -
Bupropion-Induced Dystonia: A Case Report
por: Zahra, Tafseer, et al.
Publicado: (2022) -
Leukocytosis and alteration of hemoglobin level in patients with severe COVID‐19: Association of leukocytosis with mortality
por: Sayad, Babak, et al.
Publicado: (2020)